Hemochromatosis - modern condition of the problem


Cite item

Full Text

Abstract

The iron overload syndrome can be associated with various acquired states and hereditary factors. Hereditary hemochromatosis is the most common genetic disorder. Without therapeutic intervention the disease can lead to the development of life-threatening complications such as cirrhosis, hepatocellular carcinoma. The article presents data on pathogenesis, diagnosis and treatment of hereditary hemochromatosis. Own clinical observation is given.

About the authors

N B Voloshina

Novosibirsk State Medical University FGBOU in the NSMU of the Ministry of Health of Russia

к.м.н., доцент каф. пропедевтики внутренних болезней лечебного ф-та Новосибирск, Россия

M F Osipenko

Novosibirsk State Medical University FGBOU in the NSMU of the Ministry of Health of Russia

д.м.н., проф., зав. каф. пропедевтики внутренних болезней лечебного ф-та Новосибирск, Россия

N V Litvinova

Novosibirsk State Medical University FGBOU in the NSMU of the Ministry of Health of Russia

Email: Lina-2007@list.ru
к.м.н., доцент каф. пропедевтики внутренних болезней лечебного ф-та, orcid.org/0000-0002-9143-6330 Новосибирск, Россия

A N Voloshin

Novosibirsk City Clinical Hospital 2

врач Новосибирской городской клинической больницы 2 Новосибирск, Россия

References

  1. EASL clinical practice guidelines for HFE hemochromatosis. Journal of Hepatology. 2010; 53: 3-22. https://doi.org/10.1016/j.jhep.2010.03.001
  2. Adams P, Brissot P, Powell L.W. EASL International consensus conference on haemochromatosis. Journal of Hepatology. 2000;33:487-496. https://doi.org/10.1016/s0168-8278(01)80874-6
  3. Bacon В.R, Adams P.C, Kowdley K.V, Powell L.W, Tavill A.S. Diagnosis and management of management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases. Hepatolog. 2011; 54: 328-343. https://doi.org/10.1002/hep.24330
  4. Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Haematologica. 2009; 122: 78-86. https://doi.org/10.1159/000243791
  5. Nemeth E. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004; 306: 2090-2093. https://doi.org/10.1126/science.1104742
  6. Ganz T. Iron homeostasis: fitting the puzzle pieces together. Cell Metabolism. 2008; 7 (4): 288-290. https://doi.org/10.1016/j.cmet.2008.03.008
  7. Feder J.N, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy D.A, Basava A et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics. 1996;13:399-408. https://doi.org/ 10.1038/ng0896-399
  8. Bardou-Jacquet E, de Tayrac M, Mosser J, Deugnier Y. GNPAT variant associated with severe iron overload in HFE hemochromatosis. Hepatology. 2015; 62 (6): 1917-1918. https://doi.org/10.1002/hep.27854
  9. Adams P.C, Barton J.C, Mc Laren G.D, Acton R.T, Speechley M, Mc Laren C.E et al. Screening for iron overload: lessons from the Hemochromatosis and IRon Overload Screening (HEIRS) Study. Canadian Journal of Gastroenterolgy. 2009; 23 (11): 769-772. https://doi.org/10.1155/2009/ 839308
  10. Adams P.C, Reboussin D.M, Barton J.C, Mc Laren C.E, Eckfeldt J.H, Mc Laren G.D et al. Hemochromatosis and iron - overload screening in a racially diverse population. New England Journal of Medicine. 2005; 352(17): 1769-1778. https://doi.org/10.1056/nejmoa041534
  11. Philippe M.A. Role of iron in hepatic fibrosis: one piece in the puzzle. World J Gastroenterol. 2007; 13 (35):4746. https://doi.org/10.3748/ wjg.v13.i35.4746
  12. Allen K.J et al. Iron - overload - related disease in HFE hereditary hemo - chromatosis. New England Journal of Medicine. 2008; 358 (21): 2293-2295. https://doi.org/10.1056/nejmc080330
  13. Asberg A, Hveem K, Thorstensen K. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol. 2001;36(10):1108-1115. https://doi.org/10.1080/003655201750422747
  14. Warne C.D, Zaloumis S.G, Bertalli N.A, Delatycki M.B et al. HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype - stratified cohort study of hemochromatosis in Australian women. J Gastroenterol Hepatol. 2017; 32 (4): 797-802. https://doi.org/10.1111/jgh.13621
  15. Powell L.W, Seckington R.C, Deugnier Y. Haemochromatosis. Lancet. 2016; 388(10045): 706-716. https://doi.org/10.1016/s0140-6736(15) 01315-x
  16. Wood M.J, Crawford D.H.G, Wockner L.F, Powell L.W, Ramm G.A. Serum ferritin concentration predicts hepatic fibrosis better than hepatic iron concentration in human HFE-Haemochromatosis. Liver International. 2017; 37(9): 1382-1388. https://doi.org/10.1111/liv.13395
  17. Allen K.J, Gurrin L.C, Constantine C.C et al. Iron - overload - disease in HFE hereditary hemochromatosis. New England Journal of Medicine. 2008; 358 (21): 2293-2295. https://doi.org/10.1056/nejmc080330
  18. Allen K.J et al. HFE C282Y homozygotes with serum ferritin concentrations below 1000 lg/l are et low risk of hemochromatosis. Hepatology. 2010; 52 (3): 925-933. https://doi.org/10.1002/hep.23786
  19. Moretti D, van Doorn G.M, Swinkels D.W, Melse-Boonstra A. Relevance of dietary iron intake and bioavailability in the management of HFE hemochromatosis: a systematic review. American Journal of Clinical Nutricion. 2013; 98 (2): 468-479. https://doi.org/10.3945/ ajcn.112.048264
  20. Harrison-Findik D.D, Schafer D, Klein E et al. Alcohol metabolism - mediated oxidative stress down - regulates hepcidin transcription and leads to increased duodenal iron transporter expression. Journal of Biological Chemistry. 2006; 281 (32): 22974-22982. https://doi.org/10.1074/ jbc.m602098200
  21. Harrison-Findik D.D, Klein E, Crist C, Evans J, Timchenko N, Gollan J. Iron - mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol. Hepatology. 2007;46(6):1979-1985. https://doi.org/10.1002/hep.21895
  22. Delatycki M.B, Gurrin L.C, Ong S.Y et al. Reduced mortality due to phlebotomy in moderately iron - loaded HFE haemochromatosis? The need for clinical trials. Journal of Hepatology. 2015;63(1):282-283. https://doi.org/10.1016/j.jhep.2015.03.028
  23. Stefashyna O, Stern M, Infanti L, Holbro A et al. Pattern of care of blood donors with early - uncomplicated hereditary haemochromatosis in a Swiss blood donation centre. Vox Sanguinis. 2013;106(2):111-117. https://doi.org/10.1111/vox.12078
  24. Phatak P, Brissot P, Wurster M et al. A phase 1/2, dose - escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis. Hepatology. 2010;52(5):1671-1779. https://doi.org/ 10.1002/hep.23879
  25. Rombout-Sestrienkova E, van Kraaij M.G.J, Koek G.H. How we manage patients with hereditary haemochromatosis. British Journal of Haematology. 2016; 175(5): 759-770. https://doi.org/10.1111/bjh.14376

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies